Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (23.454)

61

Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Seiwert, T. | Wildsmith, S. | Fayette, J. | +14

62

Mirikizumab for the Management of Ulcerative Colitis

enthalten in: Gastroenterology | 2024

von Venkateswaran, N.

63

Four-year long-term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis : A real-world retrospective study

enthalten in: The Journal of dermatology | 2024

von Kang, D. | Kwon, S. | Lew, B.

64

Dupilumab for moderate-severe atopic dermatitis : a real-world, single-center retrospective study of 122 patients in the United States

enthalten in: International journal of dermatology | 2024

von Emmerich, V. | Williams, J. | Hrin, M. | +2

65

Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045) : A phase II umbrella trial

enthalten in: Gynecologic oncology | 2024

von Kim, S. | Joung, J. | Kim, Y. | +12

66

Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia : A Randomized Clinical Trial

enthalten in: JAMA pediatrics | 2024

von Santos, R. | Wiegman, A. | Caprio, S. | +7

67

Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis

enthalten in: JAMA dermatology | 2024

von Blauvelt, A.

68

Nirsevimab : A Review

enthalten in: Pediatric allergy, immunology, and pulmonology | 2024

von Balbi, H.

69

Efficacy and safety of galcanezumab as chronic cluster headache preventive treatment under real world conditions : Observational prospective study

enthalten in: Cephalalgia : an international journal of headache | 2024

von Lamas Pérez, R. | Millán-Vázquez, M. | González-Oria, C.

70

The JAVELIN Bladder Medley trial : avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma

enthalten in: Future oncology (London, England) | 2024

von Hoffman-Censits, J. | Grivas, P. | Powles, T. | +7